 |
|
 |
Attributes
of Silver Particles and Solutions |
 |
Then one auspicious day, we came across
a case of chronic bronchitis that failed to completely respond to silver.
To rise to the challenge, we went on a search for the perfect complimentary
therapy. We thus ended up developing the cayenne pepper and colloidal
silver nebulizing protocol ( the cayenne is NOT nebulized ). Read our research page on cayenne
pepper and colloidal silver. Still have doubts about the protocol?
Then read the words of M. Hoal, who describes using this protocol to
beat a long term problem with emphysema,
bronchitis and a psuedomonas infection.
Author: Francis Key Items both in brackets and italicized are editor additions to the text, and do not necessarily represent the views of the author(s). Items with linked text provide definitions and/or further explanations provided by the editors, not the author. Javascript must be enabled to view the extra comments. A temporary popup window will load and stay on-screen as long as the mouse is over the linked text. Position the linked text toward the bottom of your computer screen for viewing purposes.
[ note: a silver ion is approximately .28 nanometers ]
(C) Copyright Silver-Colloids.com [ Francis Key, is a researcher specializing in the production of extremely minute ( 1.4 NM ) silver particles in colloidal suspension. The operative goal is to create small enough silver particles to be fully bioavailable, and to achieve the greatest possible surface area for efficacy. Further, the operative theory is that by utilizing silver in particle form, silver chloride is not produced in the stomach or bloodstream. Silver in its original, isolated form, may then reach areas of the body that silver in ionic form may not. ]
times since August 2009
Silver Colloidal Silver & the University of North Texas ----
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Page Last Modified: 08/23/17 06:18
Comments (0)